Allurion Technologies (ALURW) Shares Outstanding (Weighted Average) (2022 - 2026)
Allurion Technologies (ALURW) reported Shares Outstanding (Weighted Average) of $13.4 million for Q1 2026, up 179.39% on a YoY basis from $4.8 million in Q1 2025, and up 76.96% quarter-over-quarter from $7.5 million in Q4 2025.
Allurion Technologies (ALURW) Shares Outstanding (Weighted Average) (2022 - 2026) Analysis & Trends
Allurion Technologies has reported Shares Outstanding (Weighted Average) for 5 years, with the latest figure at $13.4 million in Q1 2026.
- For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 179.39% year-over-year to $13.4 million; the trailing twelve-month figure through Mar 2026 stood at $13.4 million (up 179.39% YoY), and the FY2025 full-year result was $7.5 million, up 235.74% from the prior year.
- Shares Outstanding (Weighted Average) for Q1 2026 stood at $13.4 million, up from $7.5 million in the prior quarter.
- The five-year high for Shares Outstanding (Weighted Average) was $26.9 million in Q3 2022, with the low at $1.1 million in Q4 2022.
- Historically, Shares Outstanding (Weighted Average) has averaged $5.5 million across 5 years, with a median of $2.2 million in 2024.
- Annual changes were most pronounced in 2023 — Shares Outstanding (Weighted Average) slumped 95.31% — and 2025, when it jumped 280.66%.
- Allurion Technologies' Shares Outstanding (Weighted Average) stood at $1.1 million in 2022, then jumped by 32.18% to $1.4 million in 2023, then soared by 57.89% to $2.2 million in 2024, then surged by 235.74% to $7.5 million in 2025, then jumped by 76.96% to $13.4 million in 2026.
- The last three Shares Outstanding (Weighted Average) figures came in at $13.4 million (Q1 2026), $7.5 million (Q4 2025), and $6.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.28 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 385.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 456.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 98.20 Mn |
| 10 | Allurion Technologies | - | - | 1.23 Mn | 13.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.35 Mn |
| Dec 31, 2025 | 7.54 Mn |
| Sep 30, 2025 | 6.62 Mn |
| Jun 30, 2025 | 7.30 Mn |
| Mar 31, 2025 | 4.78 Mn |
| Dec 31, 2024 | 2.25 Mn |
| Sep 30, 2024 | 2.13 Mn |
| Jun 30, 2024 | 1.92 Mn |
| Mar 31, 2024 | 1.91 Mn |
| Dec 31, 2023 | 1.42 Mn |
| Sep 30, 2023 | 1.26 Mn |
| Jun 30, 2023 | 1.08 Mn |
| Mar 31, 2023 | 1.08 Mn |
| Dec 31, 2022 | 1.08 Mn |
| Sep 30, 2022 | 26.93 Mn |
| Jun 30, 2022 | 7.44 Mn |